🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Psilocybin is a classic serotonergic hallucinogen acting on the 5-HT2A rece...
Status
Completed
Location
University Hospital Basel, Clinical Trial Unit
Start Date
2019-07-04
Trial ID
NCT03912974
Treatments Being Tested
Psilocybin, the chemical component of "magic mushrooms", has been administe...
Status
Active Not Recruiting
Location
Centre for Addiction and Mental Health
Start Date
2024-09-01
Trial ID
NCT06299319
Treatments Being Tested
MLS101 is being developed as a low dose psilocybin, that can be administere...
Status
Completed
Location
CMAX Clinical Research
Start Date
2024-11-08
Trial ID
NCT06643637
Treatments Being Tested
Psilocybin is a naturally occurring psychedelic compound produced by more t...
Status
Completed
Location
University of Wisconsin, School of Pharmacy
Start Date
2014-06
Trial ID
NCT02163707
Treatments Being Tested
The goal of this clinical trial is to investigate treatment with psilocybin...
Status
Unknown
Location
Sabi Mind
Start Date
2022-05-02
Trial ID
NCT05646303
Treatments Being Tested
Diverse symptomatology makes Fragile X Syndrome (FXS) difficult to treat, a...
Status
Suspended
Location
KGK Science Inc.
Start Date
2023-03-28
Trial ID
NCT05832255
Treatments Being Tested
This phase II trial tests the safety and side effects of psilocybin in comb...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-01-01
Trial ID
NCT07216404
Treatments Being Tested
The purpose for this study is to observe the real world experience of parti...
Status
Active Not Recruiting
Location
Innertrek Patient Service Center
Start Date
2025-03-05
Trial ID
NCT07189988
Treatments Being Tested
This study aims to explore the safety and tolerability of a single dose of ...
Status
Completed
Location
Sheppard Pratt Health System
Start Date
2022-03-28
Trial ID
NCT05220410
Treatments Being Tested
This exploratory open-label phase 1b, ascending dose study is to evaluate t...
Status
Terminated
Location
King's College London
Start Date
2021-08-11
Trial ID
NCT04905121
Treatments Being Tested